Pediatrix Medical Group Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
MEDNAX (MD) Misses Q2 EPS by 1c
August 4, 2022 6:13 AM EDTMEDNAX (NYSE: MD) reported Q2 EPS of $0.47, $0.01 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $486 million versus the consensus estimate of $493.67 million.
For earnings history and earnings-related data on MEDNAX (MD) click here.
... More